Dupilumab Skin Barrier Function Study in Atopic Dermatitis

Clinical trial NCT04447417 · COMPLETED

Trial details

NCT number: NCT04447417
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Atopic Dermatitis

Start date: 2020-07-16
Primary completion: 2021-06-17
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.